Desmoplastic malignant melanoma

H G Skelton1, K J Smith, W B Laskin

  • 1Department of Dermatopathology, Armed Forces Institute of Pathology, Washington, DC 20306-6000, USA.

Summary

Desmoplastic malignant melanoma (DMM) shows a better prognosis than other melanomas, with a 5-year disease-free survival rate of 61%. Tumor depth and stromal mucin presence are key factors influencing survival in DMM patients.